Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Cancer Genetics Inc (CGIX)
Cancer Genetics Inc (CGIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cancer Genetics Inc 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 USA

www.cancergenetics.com P: 201-528-9200 F: 201-528-9201

Description:

Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also offers non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. Cancer Genetics, Inc. is headquartered in Rutherford, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 18,833
Shares Outstanding, K 4,085
Annual Sales, $ 7,310 K
Annual Net Income, $ -6,710 K
Last Quarter Sales, $ 1,570 K
Last Quarter Net Income, $ -1,350 K
60-Month Beta 2.72
% of Insider Shareholders 15.00%
% of Institutional Shareholders 8.92%
Float, K 3,472
% Float 85.00%

Growth:

1-Year Return 49.68%
3-Year Return -87.19%
5-Year Return -94.22%
5-Year Revenue Growth -28.33%
5-Year Earnings Growth 96.07%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/18/20
Earnings Per Share ttm -2.10
EPS Growth vs. Prev Qtr 29.27%
EPS Growth vs. Prev Year -81.25%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 10/25/19

CGIX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -76.14%
Return-on-Assets % -35.58%
Profit Margin % -91.79%
Debt/Equity 0.02
Price/Sales 1.59
Price/Cash Flow 41.72
Price/Book 2.40
Book Value/Share 1.92
Interest Coverage -4.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar